Invesco India Contra Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 17-10-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate capital appreciation by investing predominantly in Equity and Equity Related Instruments through contrarian investing.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Invesco India Contra Fund - Growth 0.36 0.55 0.12 20.90 22.59 15.22
BSE 500 - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Invesco India Contra Fund - Growth Apr 11, 2007 0.12 20.90 22.59 1.64 19,169.54
SBI CONTRA FUND - REGULAR PLAN -GROWTH Jul 05, 1999 -1.39 20.91 29.52 1.51 47,205.42
Kotak Contra Fund - Regular Plan - Growth Jul 27, 2005 1.41 22.60 23.39 1.85 4,715.62

Fund Holdings as on 30-September-2025

  • HDFC Bank Limited

  • ICICI Bank Limited

  • Infosys Limited

  • Mahindra & Mahindra Limited

  • Eternal Limited

  • Larsen & Toubro Limited

  • Axis Bank Limited

  • Apollo Hospitals Enterprise Limited

  • Triparty Repo

  • Cholamandalam Investment and Finance Company Limited

  • Coforge Limited

  • Bharti Airtel Ltd Partly Paid 1.25 FV

  • Bharat Electronics Limited

  • Kotak Mahindra Bank Limited

  • Glenmark Pharmaceuticals Limited

  • Avenue Supermarts Limited ‡

  • REC Limited

  • Prestige Estates Projects Limited

  • TVS Motor Company Limited

  • KEI Industries Limited

  • Cohance Lifesciences Limited

  • Hindustan Petroleum Corporation Limited

  • LTIMindtree Limited

  • The Federal Bank Limited

  • Mankind Pharma Limited

  • FSN E-Commerce Ventures Limited ‡

  • Global Health Limited

  • Lupin Limited

  • ICICI Lombard General Insurance Company Limited

  • Ambuja Cements Limited

  • Varun Beverages Ltd

  • Shyam Metalics and Energy Limited

  • Multi Commodity Exchange of India Limited

  • Divi's Laboratories Limited

  • Samvardhana Motherson International Limited

  • Craftsman Automation Limited

  • BSE Limited

  • Voltas Limited ‡

  • Honeywell Automation India Limited

  • Entero Healthcare Solutions Ltd

  • Aditya Birla Real Estate Limited

  • Kalyan Jewellers India Limited

  • Aadhar Housing Finance Limited

  • Devyani International Limited

  • Suzlon Energy Limited

  • SBI Life Insurance Company Limited

  • IndusInd Bank Limited

  • Timken India Limited

  • Black Buck Ltd

  • Jubilant Foodworks Limited October 2025 Future

  • HDB Financial Services Limited

  • Jyoti CNC Automation Ltd

  • Delhivery Limited

  • MphasiS Limited

  • FSN E-Commerce Ventures Limited October 2025 Future

  • J B Chemicals and Pharma Ltd

  • Afcons Infrastructure Limited

  • Crompton Greaves Consumer Electricals Limited

  • Hindustan Unilever Limited October 2025 Future

  • Hindustan Unilever Limited

  • Sonata Software Limited

  • Jubilant Foodworks Limited

  • Shriram Finance Limited

  • V-Mart Retail Limited

  • Britannia Industries Limited

  • Whirlpool of India Limited

  • MedPlus Health Services Limited

  • Asian Paints Limited October 2025 Future

  • Deepak Nitrite Limited

  • Orchid Pharma Limited

  • Wockhardt Limited

  • Asian Paints Limited

  • PI Industries Limited

  • Swiggy Limited

  • Mphasis Limited October 2025 Future

  • Balkrishna Industries Limited

  • Invesco India Liquid Fund - Direct Plan - Growth

  • Lupin Limited October 2025 Future

  • REC Limited October 2025 Future

  • Voltas Limited October 2025 Future

  • Hindustan Petroleum Corporation Limited October 2025 Future

  • Larsen & Toubro Limited October 2025 Future

  • Crompton Greaves Consumer Electricals Limited October 2025 Future

  • TVS Motor Company Limited ^^

  • Glenmark Pharmaceuticals Limited October 2025 Future

  • Net Receivables / (Payables)

View More
  • Bank - Private

  • IT - Software

  • Pharmaceuticals & Drugs

  • e-Commerce

  • Hospital & Healthcare Services

  • Engineering - Construction

  • Automobiles - Passenger Cars

  • Finance - NBFC

  • Consumer Food

  • Miscellaneous

  • Retailing

  • Construction - Real Estate

  • Insurance

  • Auto Ancillary

  • Defence

  • Finance Term Lending

  • Automobile Two & Three Wheelers

  • Cable

  • Refineries

  • Logistics

  • Cement & Construction Materials

  • Steel & Iron Products

  • Finance - Stock Broking

  • Consumer Durables - Domestic Appliances

  • Air Conditioners

  • Finance - Others

  • Trading

  • Consumer Durables - Electronics

  • Diamond & Jewellery

  • Finance - Housing

  • Electric Equipment

  • Bearings

  • Engineering - Industrial Equipments

  • Household & Personal Products

  • Chemicals

  • Paints

  • Pesticides & Agrochemicals

  • Tyres & Allied

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • MFU

  • Preference Shares

  • Rights

View More

About Invesco India Contra Fund

Scheme Analysis

Invesco India Contra Fund is a Equity - Contra Fund fund and belongs to Invesco Mutual Fund. It was launched on 11-Apr-2007 and currently has an AUM of ₹19,169.54 crore. Invesco India Contra Fund is benchmarked against BSE 500 - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Invesco India Contra Fund ended up ₹0.07(0.05%)yesterday to ₹138.12.

Among its top 3 holdings the fund has exposure to HDFC Bank Limited, and

The Invesco India Contra Fund is managed by Amit Ganatra and Taher Badshah.

Fund House Contact

2101-A, A Wing, 21st Floor, Marathon Futurex, N. M. Joshi Marg, Lower Parel Mumbai - 400 013

022 - 67310000
mfservice@religare.com
022 - 23019422